글로벌 올리고뉴클레오타이드 합성 링커 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

글로벌 올리고뉴클레오타이드 합성 시장은 예측 기간 동안 개인화된 치료에 대한 강조가 증가함에 따라 빠르게 증가할 것으로 추정됩니다. 맞춤 의학은 환자의 필요와 우선순위에 따라 개인화된 치료를 포함합니다. 올리고뉴클레오타이드 합성은 환자에게 맞춤형 솔루션을 제공합니다. 터무니없는 RNA 치료법의 개발은 바이오테크 산업에서 상당한 주목을 받았습니다.

• Data Bridge Market Research는 올리고뉴클레오타이드 합성 링커 시장이 예측 기간 동안 9.95%의 CAGR로 성장할 것으로 분석했습니다. "병원"은 많은 입원 및 외래 병원 방문으로 인해 올리고뉴클레오타이드 합성 링커 시장의 최종 사용자 세그먼트에서 가장 큰 점유율을 차지했습니다. 또한 듀센 근위축증, 척수성 근위축증 및 간 정맥 폐쇄 질환과 같은 질병으로 고통받는 환자 풀의 수요를 충족하기 위한 올리고뉴클레오타이드 약물에 대한 필요성도 있습니다.

시장 정의

정의된 화학 구조를 가진 비교적 짧은 핵산 세그먼트의 화학적 합성은 올리고뉴클레오타이드 합성으로 알려져 있습니다. 이 방법은 적절한 시퀀스의 맞춤형 올리고뉴클레오타이드에 대한 빠르고 저렴한 접근을 허용하기 때문에 최근 실험실 관행에서 특히 가치가 있습니다. 만성 질환을 치료하기 위한 맞춤형 요법의 미래 사용은 올리고뉴클레오타이드 합성 때문에 이상적입니다.

올리고뉴클레오타이드 합성 링커 시장 동향

운전자

• 제약 및 생명공학 분야 확대 

제약 및 생명공학 산업 에서 연구 활동이 늘어나면서 시장 성장률에 영향을 미치는 주요 요인이 될 것입니다.

• DNA 마이크로어레이 기술의 활용

DNA 마이크로어레이 기술의 중요한 사용과 진단 치료제를 위한 올리고뉴클레오타이드 사용 및 새로운 마이크로칩 기반 올리고뉴클레오타이드 합성은 올리고뉴클레오타이드 합성 비용을 감소시켰습니다. 따라서 이러한 요인은 올리고뉴클레오타이드 합성 링커 시장에 대한 수요를 더욱 가속화할 것입니다.

Additionally, the rising awareness and focus on personalized medicine will act as a major driver influencing the oligonucleotide synthesis linkers market’s growth rate. The increase in utilization of synthesized oligos in therapeutic applications will increase the demand for oligonucleotide synthesis linkers and further propel the market’s growth rate. Another significant factor resulting in the expansion of market is the advancement of technology. Furthermore, surging healthcare spending capacity and advancement in healthcare infrastructure are the major drivers that will enhance the growth of market. Rapid urbanisation and rising government investments for synthetic biology and genome projects will influence the growth rate of oligonucleotide synthesis linkers market.

Opportunities

• Growth in R&D activities

The rise in the number of research and development activities and increasing applications from emerging countries will provide beneficial opportunities for the oligonucleotide synthesis linkers market growth. Moreover, increasing government investments for the development of technology and healthcare infrastructure will further expand the oligonucleotide synthesis linkers market’s growth rate in the future.

Restraints/Challenges

On the other hand, high cost and the dearth of funding in research and development sectors in under-developed nations will obstruct the market growth. Also, delivery of oligonucleotide drugs to specific targets will pose a major challenge for oligonucleotide synthesis linkers market. However, complications involved with therapeutic oligos and the lack of skilled professionals will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This oligonucleotide synthesis linkers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oligonucleotide synthesis linkers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Oligonucleotide Synthesis Linkers Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. A diverse group of established pharmaceutical and biopharmaceutical companies and players in the oligonucleotide synthesis market have stepped forward to support global research efforts by providing oligo products for the development of test kits, treatments, and vaccines that target the novel Coronavirus infection. The use of a wide range of oligonucleotide products such as probes and primers in COVID-19 research and other activities by market companies has helped researchers obtain a deeper understanding of the Coronavirus. As a result, the market for oligonucleotide synthesis linkers impacted positively. However, due to restrictions enforced during the COVID-19 pandemic, oligonucleotide-based medicine sales decreased slightly in 2020.

Recent Development

• In February 2021, the Centre for Process Innovation had launched a project in Medicine Manufacturing Innovation Centre in UK. Through a collaboration with AstraZeneca, Exactmer, Novartis, and UK Research & Innovation, this project aims to transform the synthesis of oligonucleotides. As a result of this agreement, Inclisiran, a small interfering RNA used to treat atherosclerotic cardiovascular disease (ASCVD), would be the first drug produced on a commercial scale.

Global Oligonucleotide Synthesis Linkers Market Scope

The oligonucleotide synthesis linkers market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Research
• Diagnostics
• Therapeutics

Based on application, oligonucleotide synthesis linkers market is segmented into research, diagnostics and therapeutics. Research has been further segmented into PCR, QPCR, sequencing, gene synthesis and others. Others have been further sub segmented into nucleic acid hybridization methods and isothermal amplification methods. Therapeutics has been segmented into DNA and antisense oligonucleotide-based therapies, RNAi oligonucleotide-based therapies and CpG oligonucleotide-based therapies.

Type

• Custom Oligonucleotides
• Pre-Designed Oligonucleotides

Based on type, oligonucleotide synthesis linkers market is segmented into custom oligonucleotides and pre-designed oligonucleotides.

End User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Hospitals

Oligonucleotide synthesis linkers market has also been segmented based on the end user into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories and hospitals

Oligonucleotide Synthesis Linkers Market Regional Analysis/Insights

The oligonucleotide synthesis linkers market is analysed and market size insights and trends are provided by country, type, application and end user as referenced above.

The countries covered in the oligonucleotide synthesis linkers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the oligonucleotide synthesis linkers market because of the greater investment in research and development and an increase in the number of oligonucleotide-based medications and therapies in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The oligonucleotide synthesis linkers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oligonucleotide synthesis linkers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oligonucleotide synthesis linkers market. The data is available for historic period 2010-2020.

Competitive Landscape and Oligonucleotide Synthesis Linkers Market Share Analysis

The oligonucleotide synthesis linkers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oligonucleotide synthesis linkers market.

올리고뉴클레오타이드 합성 링커 시장의 주요 기업으로는 Agilent Technologies, Inc., ATDBio Ltd., Bio-Synthesis Inc., BioAutomation, LGC Biosearch Technologies, Sarepta Therapeutics, Kaneka Corporation, GeneDesign, Inc., General Electric, GenScript, Integrated DNA Technologies, Inc., NITTO DENKO CORPORATION., Thermo Fisher Scientific, Inc., TriLink BioTechnologies., Danaher, Maravai LifeSciences, Biogen, Eurofins Scientific, Merck KGaA 등이 있습니다.

SKU-51865